Vasamed Financial Statements From 2010 to 2025
| VSMD Stock | USD 0.0001 0.00 0.00% |
Check Vasamed financial statements over time to gain insight into future company performance. You can evaluate financial statements to find patterns among Vasamed's main balance sheet or income statement drivers, such as , as well as many indicators such as . Vasamed financial statements analysis is a perfect complement when working with Vasamed Valuation or Volatility modules.
Vasamed |
Vasamed Company Return On Asset Analysis
Vasamed's Return on Asset or ROA shows how effective is the management of the company in generating income from utilizing all of the assets at their disposal. It is a useful ratio to evaluate the performance of different departments of a company as well as to understand management performance over time.
Current Vasamed Return On Asset | -0.74 |
Most of Vasamed's fundamental indicators, such as Return On Asset, are part of a valuation analysis module that helps investors searching for stocks that are currently trading at higher or lower prices than their real value. If the real value is higher than the market price, Vasamed is considered to be undervalued, and we provide a buy recommendation. Otherwise, we render a sell signal.
Return on Asset measures overall efficiency of a company in generating profits from its total assets. It is expressed as the percentage of profits earned per dollar of Asset. A low ROA typically means that a company is asset-intensive and therefore will needs more money to continue generating revenue in the future.
| Competition |
Based on the latest financial disclosure, Vasamed has a Return On Asset of -0.741. This is 91.53% lower than that of the Health Care Equipment & Supplies sector and 97.45% lower than that of the Health Care industry. The return on asset for all United States stocks is notably higher than that of the company.
Vasamed Fundamental Drivers Relationships
Comparative valuation techniques use various fundamental indicators to help in determining Vasamed's current stock value. Our valuation model uses many indicators to compare Vasamed value to that of its competitors to determine the firm's financial worth. You can analyze the relationship between different fundamental ratios across Vasamed competition to find correlations between indicators driving Vasamed's intrinsic value. More Info.Vasamed is rated first in return on asset category among its peers. It is rated first in profit margin category among its peers . The reason why the comparable model can be used in almost all circumstances is due to the vast number of multiples that can be utilized, such as the price-to-earnings (P/E), price-to-book (P/B), price-to-sales (P/S), price-to-cash flow (P/CF), and many others. The P/E ratio is the most commonly used of these ratios because it focuses on the Vasamed's earnings, one of the primary drivers of an investment's value.About Vasamed Financial Statements
Vasamed stakeholders use historical fundamental indicators, such as Vasamed's revenue or net income, to determine how well the company is positioned to perform in the future. Although Vasamed investors may analyze each financial statement separately, they are all interrelated. For example, changes in Vasamed's assets and liabilities are reflected in the revenues and expenses on Vasamed's income statement, which ultimately affect the company's gains or losses. Understanding these patterns can help in making the right long-term investment decisions in Vasamed. Please read more on our technical analysis and fundamental analysis pages.
Vasamed Incorporated designs, licenses, manufactures, and distributes products, software, and services for assessing and managing hemodynamic health in the United States. The company was founded in 1988 and is headquartered in Eden Prairie, Minnesota. Vasamed operates under Medical Instruments Supplies classification in the United States and is traded on OTC Exchange.
Also Currently Popular
Analyzing currently trending equities could be an opportunity to develop a better portfolio based on different market momentums that they can trigger. Utilizing the top trending stocks is also useful when creating a market-neutral strategy or pair trading technique involving a short or a long position in a currently trending equity.Other Information on Investing in Vasamed Pink Sheet
Vasamed financial ratios help investors to determine whether Vasamed Pink Sheet is cheap or expensive when compared to a particular measure, such as profits or enterprise value. In other words, they help investors to determine the cost of investment in Vasamed with respect to the benefits of owning Vasamed security.